| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e7022e391363a3cf3486bf3859ce0a7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 |
| filingDate |
2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_692b942d613b4d965d1c6fddf110f2d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b2fabf4ddd6f4e7da34a8b3074e4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd5b28b00e2aff6157e27a9c911e0db |
| publicationDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1209159-A2 |
| titleOfInvention |
Anhydrous mirtazapine and process for preparing the same |
| abstract |
Methods for producing anhydrous mirtazapine crystals that are either (1)nsubstantially free of lower alcohol insolubles or (2) substantially free of residualnsolvent and have an average particle diameter of from 10 to 50 µm, are provided,nand the resulting anhydrous mirtazapine crystals produced thereby, which arenuseful in pharmaceuticals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007298107-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603272-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005051349-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101541798-B |
| priorityDate |
2000-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |